Unveiling Macrophage Dynamics and Efferocytosis-related Targets in Diabetic Kidney Disease: Insights from Single-cell and Bulk RNA-sequencing

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2025 Mar 6

PMID 40046045

Authors

Binshan Zhang

Yunqi Wu

Zhongli Wang

Suhua Gao

Hongyan Liu

Yao Lin

Pei Yu

Affiliations

Soon will be listed here.

Abstract

Background: Chronic inflammation and immune imbalance mediated by macrophages are considered pivotal in diabetic kidney disease (DKD). The study aims to clarify the macrophage heterogeneity and phenotype dynamics, and pinpoint critical targets within efferocytosis in DKD.

Methods: Utilizing early human DKD sequencing data, we computed the potential communication between leukocytes and renal intrinsic cells. Subsequently, we scrutinized the single-cell RNA sequencing (scRNA-seq) data from CD45-enriched immune cells, concentrating on the macrophage subsets in DKD. Pseudotime trajectory analysis was conducted to explore cell development. Differential expression genes (DEGs) from macrophage subgroups and bulk RNA-sequencing were used to identify shared hub genes. The NephroseqV5 platform was employed to evaluate the clinical significance, and the expression of key molecules was validated in DKD tissues.

Results: Macrophage infiltration rose in DKD, causing inflammation through the release of chemokines. As time progressed, the number of resident macrophages substantially dropped, with diminishing M1-like and increasing M2-like phenotypes relative to early stages. Further analysis pointed to the most enrichment of macrophage function is the phagosome. We overlapped the DEGs with efferocytosis-related genes and identified key genes, including CD36, ITGAM, and CX3CR1, which exhibited significant correlations with macrophages and T cells. The Nephroseq database revealed that they are associated with proteinuria and renal function. Consistent with the validation set, experiments verified elevated expression levels of key molecules.

Conclusions: In essence, our research elucidated the dynamics in macrophage subtype transitions. It emphasized three pivotal genes as critical modulators of macrophage efferocytosis in DKD, indicating their potential as innovative biomarkers and therapeutic targets.

References

DeLeon-Pennell K, Tian Y, Zhang B, Cates C, Padmanabhan Iyer R, Cannon P . CD36 Is a Matrix Metalloproteinase-9 Substrate That Stimulates Neutrophil Apoptosis and Removal During Cardiac Remodeling. Circ Cardiovasc Genet. 2015; 9(1):14-25. PMC: 4758866. DOI: 10.1161/CIRCGENETICS.115.001249. View

Qiu S, Liu J, Chen J, Li Y, Bu T, Li Z . Targeted delivery of MerTK protein via cell membrane engineered nanoparticle enhances efferocytosis and attenuates atherosclerosis in diabetic ApoE Mice. J Nanobiotechnology. 2024; 22(1):178. PMC: 11015613. DOI: 10.1186/s12951-024-02463-y. View

Ritchie M, Phipson B, Wu D, Hu Y, Law C, Shi W . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015; 43(7):e47. PMC: 4402510. DOI: 10.1093/nar/gkv007. View

Herb M, Gluschko A, Schramm M . LC3-associated phagocytosis initiated by integrin ITGAM-ITGB2/Mac-1 enhances immunity to Listeria monocytogenes. Autophagy. 2018; 14(8):1462-1464. PMC: 6103671. DOI: 10.1080/15548627.2018.1475816. View

Shah R, Hinkle C, Ferguson J, Mehta N, Li M, Qu L . Fractalkine is a novel human adipochemokine associated with type 2 diabetes. Diabetes. 2011; 60(5):1512-8. PMC: 3292325. DOI: 10.2337/db10-0956. View

Friggeri A, Banerjee S, Biswas S, de Freitas A, Liu G, Bierhaus A . Participation of the receptor for advanced glycation end products in efferocytosis. J Immunol. 2011; 186(11):6191-8. PMC: 3955180. DOI: 10.4049/jimmunol.1004134. View

Davis K, Banerjee S, Friggeri A, Bell C, Abraham E, Zerfaoui M . Poly(ADP-ribosyl)ation of high mobility group box 1 (HMGB1) protein enhances inhibition of efferocytosis. Mol Med. 2011; 18:359-69. PMC: 3356430. DOI: 10.2119/molmed.2011.00203. View

Bilen A, Calik I, Yayla M, Dincer B, Tavaci T, Cinar I . Does daily fasting shielding kidney on hyperglycemia-related inflammatory cytokine via TNF-α, NLRP3, TGF-β1 and VCAM-1 mRNA expression. Int J Biol Macromol. 2021; 190:911-918. DOI: 10.1016/j.ijbiomac.2021.08.216. View

Zheng C, Sui B, Zhang X, Hu J, Chen J, Liu J . Apoptotic vesicles restore liver macrophage homeostasis to counteract type 2 diabetes. J Extracell Vesicles. 2021; 10(7):e12109. PMC: 8144839. DOI: 10.1002/jev2.12109. View

10.

Doran A, Yurdagul Jr A, Tabas I . Efferocytosis in health and disease. Nat Rev Immunol. 2019; 20(4):254-267. PMC: 7667664. DOI: 10.1038/s41577-019-0240-6. View

11.

Nagashimada M, Sawamoto K, Ni Y, Kitade H, Nagata N, Xu L . CX3CL1-CX3CR1 Signaling Deficiency Exacerbates Obesity-induced Inflammation and Insulin Resistance in Male Mice. Endocrinology. 2021; 162(6). DOI: 10.1210/endocr/bqab064. View

12.

Wilson P, Wu H, Kirita Y, Uchimura K, Ledru N, Rennke H . The single-cell transcriptomic landscape of early human diabetic nephropathy. Proc Natl Acad Sci U S A. 2019; 116(39):19619-19625. PMC: 6765272. DOI: 10.1073/pnas.1908706116. View

13.

Rayego-Mateos S, Rodrigues-Diez R, Fernandez-Fernandez B, Mora-Fernandez C, Marchant V, Donate-Correa J . Targeting inflammation to treat diabetic kidney disease: the road to 2030. Kidney Int. 2022; 103(2):282-296. DOI: 10.1016/j.kint.2022.10.030. View

14.

Rosetti F, Mayadas T . The many faces of Mac-1 in autoimmune disease. Immunol Rev. 2015; 269(1):175-93. DOI: 10.1111/imr.12373. View

15.

Li C, Menoret A, Farragher C, Ouyang Z, Bonin C, Holvoet P . Single cell transcriptomics based-MacSpectrum reveals novel macrophage activation signatures in diseases. JCI Insight. 2019; 5. PMC: 6542613. DOI: 10.1172/jci.insight.126453. View

16.

Mehrotra P, Ravichandran K . Drugging the efferocytosis process: concepts and opportunities. Nat Rev Drug Discov. 2022; 21(8):601-620. PMC: 9157040. DOI: 10.1038/s41573-022-00470-y. View

17.

Zimmerman K, Bentley M, Lever J, Li Z, Crossman D, Song C . Single-Cell RNA Sequencing Identifies Candidate Renal Resident Macrophage Gene Expression Signatures across Species. J Am Soc Nephrol. 2019; 30(5):767-781. PMC: 6493978. DOI: 10.1681/ASN.2018090931. View

18.

Pennathur S, Pasichnyk K, Bahrami N, Zeng L, Febbraio M, Yamaguchi I . The macrophage phagocytic receptor CD36 promotes fibrogenic pathways on removal of apoptotic cells during chronic kidney injury. Am J Pathol. 2015; 185(8):2232-45. PMC: 4530136. DOI: 10.1016/j.ajpath.2015.04.016. View

19.

Suchanek O, Ferdinand J, Tuong Z, Wijeyesinghe S, Chandra A, Clauder A . Tissue-resident B cells orchestrate macrophage polarisation and function. Nat Commun. 2023; 14(1):7081. PMC: 10625551. DOI: 10.1038/s41467-023-42625-4. View

20.

Zhang H, You G, Yang Q, Jin G, Lv G, Fan L . CX3CR1 deficiency promotes resolution of hepatic ischemia-reperfusion injury by regulating homeostatic function of liver infiltrating macrophages. Biochim Biophys Acta Mol Basis Dis. 2024; 1870(5):167130. DOI: 10.1016/j.bbadis.2024.167130. View